These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18932068)

  • 21. THE Hb S/beta+ -thalassemia phenotype demonstrates that the IVS-I (-2) (A>C) mutation is a mild beta-thalassemia allele.
    Schmugge M; Waye JS; Basran RK; Zurbriggen K; Frischknecht H
    Hemoglobin; 2008; 32(3):303-7. PubMed ID: 18473247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The IVS-II-1 (G-->a) beta0-thalassemia mutation in cis with HbA2-Troodos [delta116(G18)Arg-->Cys (CGC-->TGC)] causes a complex prenatal diagnosis in an Iranian family.
    Eram SM; Azimifar B; Abolghasemi H; Foulady P; Lotfi V; Masrouri M; Hosseini M; Abdolhosseini A; Zeinali S
    Hemoglobin; 2005; 29(4):289-92. PubMed ID: 16370491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The molecular pathology of beta-thalassemia in Turkey: the Boğaziçi university experience.
    Basak AN
    Hemoglobin; 2007; 31(2):233-41. PubMed ID: 17486506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delta-thalassemia in Cyprus.
    Pavlou E; Phylactides M; Kyrri A; Kalogerou E; Makariou C; Georgiou I; Kleanthous M
    Hemoglobin; 2006; 30(4):455-62. PubMed ID: 16987800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta thalassemia IVS-I-5(G-->C) heterozygosity masked by the presence of HbJ-Meerut in a Dutch-Indian patient.
    Giordano PC; Maatman RG; Niessen RW; van Delft P; Harteveld CL
    Haematologica; 2006 Dec; 91(12 Suppl):ECR56. PubMed ID: 17194662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening of Iranian thalassemic families for the most common deletions of the beta-globin gene cluster.
    Esteghamat F; Imanian H; Azarkeivan A; Pourfarzad F; Almadani N; Najmabadi H
    Hemoglobin; 2007; 31(4):463-9. PubMed ID: 17994380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular epidemiology investigation of beta-thalassemia in Zhongshan City, Guangdong Province, People's Republic of China.
    Zhang CM; Wang Y; Gao LS; Gao JH; He XL; Feng HJ; Liao JL
    Hemoglobin; 2010; 34(1):55-60. PubMed ID: 20113289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. beta-Thalassemia mutations in the Iranian Kurdish population of Kurdistan and West Azerbaijan provinces.
    Haghi M; Khorshidi S; Hosseinpour Feizi MA; Pouladi N; Hosseinpour Feizi AA
    Hemoglobin; 2009; 33(2):109-14. PubMed ID: 19373586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hb Lepore-Leiden: a new delta/beta rearrangement associated with a beta-thalassemia minor phenotype.
    Harteveld CL; Wijermans PW; Arkesteijn SG; Van Delft P; Kerkhoffs JL; Giordano PC
    Hemoglobin; 2008; 32(5):446-53. PubMed ID: 18932069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homozygosity for a rare beta 0-thalassemia mutation [frameshift codons 25/26 (+T)] causes beta-thalassemia intermedia in an Iranian family.
    Haghi M; Feizi AA; Harteveld CL; Pouladi N; Feizi MA
    Hemoglobin; 2009; 33(1):75-80. PubMed ID: 19205978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thalassemias and other hemoglobinopathies in the Republic of Macedonia.
    Efremov GD
    Hemoglobin; 2007; 31(1):1-15. PubMed ID: 17365000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations.
    Verma IC; Kleanthous M; Saxena R; Fucharoen S; Winichagoon P; Raizuddin S; Khan SN; Akbari MT; Izadyar M; Kotea N; Old JM; Ioannou PA; Khan B
    Hemoglobin; 2007; 31(4):439-52. PubMed ID: 17994378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [IDENTIFICATION OF MUTATION IVS1-5(G > C) OF THE β-HEMOGLOBIN GENE (Hbβ) BY RDBH-METHOD IN PATIENTS WITH β-THALASSEMIA IN AZERBAIJAN].
    Akbarova G
    Tsitol Genet; 2015; 49(3):40-4. PubMed ID: 26214904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of borderline hemoglobin A2 values in an Italian population with a high prevalence of beta-thalassemia.
    Giambona A; Passarello C; Vinciguerra M; Li Muli R; Teresi P; Anzà M; Ruggeri G; Renda D; Maggio A
    Haematologica; 2008 Sep; 93(9):1380-4. PubMed ID: 18603555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical significance of the spectrum of interactions of CAP+1 (A-->C), a silent beta-globin gene mutation, with other beta-thalassemia mutations and globin gene modifiers in north Indians.
    Garewal G; Das R; Awasthi A; Ahluwalia J; Marwaha RK
    Eur J Haematol; 2007 Nov; 79(5):417-21. PubMed ID: 17900295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hb A2' (Hb B2) in the Omani population and diagnostic significance.
    Daar S; Al Zadjali S; Gravell D; Al Haddabi H; Al Riyami M; Al Belushi A; Berbar T; Krishnamoorthy R
    Hemoglobin; 2011; 35(2):117-24. PubMed ID: 21417568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Observation of a rare hemoglobin variant [Hb Lulu island, beta107(G9)Gly-->Asp, GGC-->GAC] co-inherited with a beta+-thalassemia mutation [IVS-I-110 (G-->A)] or in the heterozygous state in a Greek-Albanian family.
    Papassotiriou I; Stamoulakatou A; Wajcman H; Kister J; Dimisianos G; Lazaropoulou C; Kanavaki I; Vavourakis E; Kattamis A; Kanavakis E; Traeger-Synodinos J
    Hemoglobin; 2006; 30(4):409-18. PubMed ID: 16987796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence and molecular basis of beta-thalassemia in Isparta province and region.
    Tunç B; Cetin H; Gümrük F; Istanbullu B; Yavrucuoğlu H; Kurt U; Genç H
    Turk J Pediatr; 2002; 44(1):18-20. PubMed ID: 11858373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and hematological parameters of thalassemia in Tha Kradarn subdistrict Chachoengsao Province, Thailand.
    Nillakupt K; Nathalang O; Arnutti P; Jindadamrongwech S; Boonsiri T; Panichkul S; Areekul W
    J Med Assoc Thai; 2012 May; 95 Suppl 5():S124-32. PubMed ID: 22934458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two rare mutations in Turkey: IVS I.130(G-C) and IVS II.848(C-A).
    Nal N; Manguoglu AE; Sargin CF; Keser I; Kupesiz A; Yesilipek A; Luleci G
    Clin Lab Haematol; 2005 Aug; 27(4):274-7. PubMed ID: 16048497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.